157 related articles for article (PubMed ID: 32690855)
1. Preoperative Platelet to Lymphocyte Ratio as a Prognostic Factor for Resectable Pancreatic Cancer: A Systematic Review and Meta-Analysis.
Riauka R; Ignatavicius P; Barauskas G
Dig Surg; 2020; 37(6):447-455. PubMed ID: 32690855
[TBL] [Abstract][Full Text] [Related]
2. Preoperative independent prognostic factors in patients with borderline resectable pancreatic ductal adenocarcinoma following curative resection: the neutrophil-lymphocyte and platelet-lymphocyte ratios.
Asari S; Matsumoto I; Toyama H; Shinzeki M; Goto T; Ishida J; Ajiki T; Fukumoto T; Ku Y
Surg Today; 2016 May; 46(5):583-92. PubMed ID: 26108488
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Significance of Preoperative Neutrophil-to-Lymphocyte Ratio in Surgically Resectable Pancreatic Neuroendocrine Tumors.
Zhou B; Zhan C; Wu J; Liu J; Zhou J; Zheng S
Med Sci Monit; 2017 Nov; 23():5574-5588. PubMed ID: 29168979
[TBL] [Abstract][Full Text] [Related]
4. Prognostic role of platelet to lymphocyte ratio in pancreatic cancers: A meta-analysis including 3028 patients.
Li W; Tao L; Lu M; Xiu D
Medicine (Baltimore); 2018 Feb; 97(8):e9616. PubMed ID: 29465553
[TBL] [Abstract][Full Text] [Related]
5. Increased platelet-to-lymphocytes ratio is associated with poor long-term prognosis in patients with pancreatic cancer after surgery.
Yu J; Ding Z; Yang Y; Liu S
Medicine (Baltimore); 2018 Jun; 97(25):e11002. PubMed ID: 29923983
[TBL] [Abstract][Full Text] [Related]
6. Preoperative platelet to lymphocyte ratio predicts outcome of patients with pancreatic ductal adenocarcinoma after pancreatic resection.
Shirai Y; Shiba H; Sakamoto T; Horiuchi T; Haruki K; Fujiwara Y; Futagawa Y; Ohashi T; Yanaga K
Surgery; 2015 Aug; 158(2):360-5. PubMed ID: 26032829
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of combined preoperative fibrinogen-albumin ratio and platelet-lymphocyte ratio score in patients with breast cancer: A prognostic nomogram study.
Zheng Y; Wu C; Yan H; Chen S
Clin Chim Acta; 2020 Jul; 506():110-121. PubMed ID: 32156604
[TBL] [Abstract][Full Text] [Related]
8. Combined preoperative platelet-to-lymphocyte ratio and serum carbohydrate antigen 19-9 level as a prognostic factor in patients with resected pancreatic cancer.
Sakamoto T; Saito H; Amisaki M; Tokuyasu N; Honjo S; Fujiwara Y
Hepatobiliary Pancreat Dis Int; 2019 Jun; 18(3):278-284. PubMed ID: 30987900
[TBL] [Abstract][Full Text] [Related]
9. Pretherapy neutrophil to lymphocyte ratio and platelet to lymphocyte ratio do not predict survival in resectable pancreatic cancer.
Chawla A; Huang TL; Ibrahim AM; Hardacre JM; Siegel C; Ammori JB
HPB (Oxford); 2018 May; 20(5):398-404. PubMed ID: 29221789
[TBL] [Abstract][Full Text] [Related]
10. Preoperative platelet lymphocyte ratio as independent predictors of prognosis in pancreatic cancer: A systematic review and meta-analysis.
Song W; Tian C; Wang K; Zhang RJ; Zou SB
PLoS One; 2017; 12(6):e0178762. PubMed ID: 28575033
[TBL] [Abstract][Full Text] [Related]
11. Validation and clinical usefulness of pre- and postoperative systemic inflammatory parameters as prognostic markers in patients with potentially resectable pancreatic cancer.
Hoshimoto S; Hishinuma S; Shirakawa H; Tomikawa M; Ozawa I; Ogata Y
Pancreatology; 2020 Mar; 20(2):239-246. PubMed ID: 31862230
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for breast cancer patients: An updated meta-analysis of 17079 individuals.
Guo W; Lu X; Liu Q; Zhang T; Li P; Qiao W; Deng M
Cancer Med; 2019 Aug; 8(9):4135-4148. PubMed ID: 31197958
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of preoperative lymphocyte-related systemic inflammatory biomarkers in upper tract urothelial carcinoma patients treated with radical nephroureterectomy: a systematic review and meta-analysis.
Shao Y; Li W; Wang D; Wu B
World J Surg Oncol; 2020 Oct; 18(1):273. PubMed ID: 33097052
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil to lymphocyte ratio, not platelet to lymphocyte or lymphocyte to monocyte ratio, is predictive of patient survival after resection of early-stage pancreatic ductal adenocarcinoma.
Pointer DT; Roife D; Powers BD; Murimwa G; Elessawy S; Thompson ZJ; Schell MJ; Hodul PJ; Pimiento JM; Fleming JB; Malafa MP
BMC Cancer; 2020 Aug; 20(1):750. PubMed ID: 32782024
[TBL] [Abstract][Full Text] [Related]
15. Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancer.
Sun X; Liu X; Liu J; Chen S; Xu D; Li W; Zhan Y; Li Y; Chen Y; Zhou Z
Chin J Cancer; 2016 Jun; 35(1):57. PubMed ID: 27342313
[TBL] [Abstract][Full Text] [Related]
16. Prognostic role of the pre-treatment platelet-lymphocyte ratio in pancreatic cancer: a meta-analysis.
Xu ZS; Zhang FP; Zhang Y; Ou-Yang YP; Yu XW; Wang WL; Xu WJ; Luo ZQ
Oncotarget; 2017 Nov; 8(58):99003-99012. PubMed ID: 29228745
[TBL] [Abstract][Full Text] [Related]
17. Preoperative platelet-lymphocyte ratio is superior to neutrophil-lymphocyte ratio as a prognostic factor for soft-tissue sarcoma.
Que Y; Qiu H; Li Y; Chen Y; Xiao W; Zhou Z; Zhang X
BMC Cancer; 2015 Oct; 15():648. PubMed ID: 26432433
[TBL] [Abstract][Full Text] [Related]
18. Preoperative platelet to lymphocyte ratio is a valuable prognostic biomarker in patients with colorectal cancer.
You J; Zhu GQ; Xie L; Liu WY; Shi L; Wang OC; Huang ZH; Braddock M; Guo GL; Zheng MH
Oncotarget; 2016 May; 7(18):25516-27. PubMed ID: 27027440
[TBL] [Abstract][Full Text] [Related]
19. Stratification of Prognosis in Patients With Ampullary Carcinoma After Surgery by Preoperative Platelet-to-lymphocyte Ratio and Conventional Tumor Markers.
Kawaida H; Kono H; Amemiya H; Hosomura N; Watanabe M; Saito R; Maruyama S; Shimizu H; Furuya S; Akaike H; Kawaguchi Y; Sudo M; Matusda M; Itakura J; Shindo H; Takahashi EI; Takano S; Fukasawa M; Satou T; Nakazawa T; Enomoto N; Fujii H; Ichikawa D
Anticancer Res; 2019 Dec; 39(12):6923-6929. PubMed ID: 31810963
[TBL] [Abstract][Full Text] [Related]
20. Prognostic role of platelet to lymphocyte ratio in hepatocellular carcinoma: a systematic review and meta-analysis.
Zhao Y; Si G; Zhu F; Hui J; Cai S; Huang C; Cheng S; Fathy AH; Xiang Y; Li J
Oncotarget; 2017 Apr; 8(14):22854-22862. PubMed ID: 28206965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]